Skip to content

AN2 Therapeutics, Inc.: filings

Every AN2 Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 18 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-11fiscal Q2 202634980001193125-26-344569
10-Q2026-05-11fiscal Q1 202632680001193125-26-216755
10-K2026-03-17fiscal FY 202537760001193125-26-110693
10-Q2025-11-12fiscal Q3 202533990001193125-25-277673
10-Q2025-08-12fiscal Q2 202533960000950170-25-107301
10-Q2025-05-13fiscal Q1 202533690000950170-25-070358
10-K2025-03-25fiscal FY 202434690000950170-25-044366
10-Q2024-11-13fiscal Q3 2024341030000950170-24-126282
10-Q2024-08-13fiscal Q2 202433960000950170-24-096243
10-Q2024-05-14fiscal Q1 202433700000950170-24-059556
10-K2024-03-29fiscal FY 202337740000950170-24-038681
10-Q2023-11-09fiscal Q3 2023361050000950170-23-062081
10-Q2023-08-10fiscal Q2 2023361010000950170-23-041378
10-Q2023-05-11fiscal Q1 202336730000950170-23-021291
10-K2023-03-29fiscal FY 202236710000950170-23-010627
10-Q2022-11-09fiscal Q3 2022361050000950170-22-023901
10-Q2022-08-11fiscal Q2 2022361010000950170-22-016900
10-Q2022-05-10fiscal Q1 202232630000950170-22-008999

Inspect the source

Entity
AN2 Therapeutics, Inc. / CIK 0001880438
Captured
2026-09-21T17:32:49.699Z
SEC response SHA-256
6448539566530f70fc3217faac996217571506e5201bea348f13fd4a1bb6afdd

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001880438.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))